What is WeighLess MD?
Founded in 2015 by Cheri Stoka, WeighLess MD operates at the intersection of clinical medicine and personalized wellness. The company provides a comprehensive suite of services, including weight loss injections, metabolic health assessments, and gut wellness programs, designed to move beyond traditional dieting. By focusing on the underlying imbalances that contribute to weight gain, the firm has established a repeatable and scalable framework. Beyond its direct-to-consumer clinical services, WeighLess MD has successfully transitioned into a franchise model, enabling practitioners to deploy its evidence-based protocols across new geographic markets, thereby broadening its impact on the national obesity crisis.
How much funding has WeighLess MD raised?
WeighLess MD has raised a total of $62K across 1 funding round:
Debt
$62K
Debt (2021): $62K with participation from PPP
Key Investors in WeighLess MD
PPP
Public-Private Partnership
What's next for WeighLess MD?
With the recent influx of capital, WeighLess MD is expected to prioritize the expansion of its franchise network and the enhancement of its digital health infrastructure. The company's strategic roadmap likely involves deepening its investment in metabolic research and refining its diagnostic testing capabilities to maintain a competitive edge in the weight management industry. As the firm scales, the focus will remain on operational excellence and the standardization of its clinical outcomes, ensuring that the brand remains a leader in the medical weight loss space while navigating the complexities of a rapidly evolving healthcare landscape.
See full WeighLess MD company page
